News

Oxygen Biotherapeutics has received approval from Israel’s Ministry of Health to begin a phase II-b, dose escalation, clinical trial in the country for use of Oxycyte in traumatic

Gerresheimer, a pharmaceutical packaging manufacturer, has opened a R&D center in the US. It has also inaugurated a new factory in Spain for plastic drugs packaging. The company

Vetter, a provider of Pre-filled Injection Systems, will open Vetter Development Service (VDS), a technologically advanced customer service facility located in Chicago, allowing the company to focus on

Q Chip, a biopharmaceutical drug delivery company, is developing a range of sustained-release biosimilars using its patented Q-Sphera bioencapsulation platform. Q-Sphera is an enabling technology for peptide and

“We are very excited about this agreement as it will launch us into the worldwide bovine tuberculosis testing market. This affliction costs the worldwide cattle industry billions of

DATATRAK International has announced the signing of two studies exemplifying the versatility of the DATATRAK eClinical platform. The first is a six-year, 400-patient registry study being conducted by

Nutra Pharma plans to begin the drug registration process in Canada and Europe for its over-the-counter (OTC) pain reliever. The company is currently marketing a similar drug in

Helsinn has provided new positive data presented at the ECCO-ESMO joint European oncology conference in Berlin, for palonosetron. Palonosetron, a second generation 5-HT3 receptor antagonist, which improves emesis

BioMarin Pharmaceutical has initiated treatment in the phase 2 clinical study of PEG-PAL (PEGylated recombinant phenylalanine ammonia lyase) for the treatment of phenylketonuria (PKU). The initial top-line results